Company
Human Immunology Biosciences (HI-Bio)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Human Immunology Biosciences (HI-Bio) is a US-based precision immunology company leveraging human genetics to deliver patient-targeted approaches to autoimmune disorders. HI-Bio is a new company that Monograph is co-incubating with Arch Venture Partners. Monograph co-led the Series A financing round in August 2021.
Loading relationship preview